2017 American Transplant Congress » Poster Session A: Kidney: Polyoma

5:30pm-7:30pm

Alemtuzumab Induction Is Associated with a Lower Incidence of BK Virus Nephropathy Compared with IL2RA Induction.

A. Gueret-Wardle, S. Hassan, G. Lucisano, C. Roufosse, M. Willicombe, D. Taube.

5:30pm-7:30pm

BK Polyoma Virus and Malignancy: Cause or Co-Incidence?

R. Prashar, A. Shah, D. Stewart, S. Williamson, A. Patel.

5:30pm-7:30pm

BK Viruria Levels within 3 Months Post Renal Transplantation Can Predict the Development of BK Viraemia.

N. Lioufas,¹ R. Masterson,^1,2 P. Hughes.

5:30pm-7:30pm

Clinical Utility of Viral miRNA in Urinary Exosomes to Diagnose BK Virus Nephropathy After Kidney Transplantation.

J.-W. Seo,¹ Y. Lee,¹ H. Moon,¹ Y. Kim,¹ K.-H. Jeong,¹ J.-Y. Moon,¹ C.-D. Kim,² J. Park,³ B. Chung,⁴ Y.-H. Kim,⁵ S.-H. Lee.¹

5:30pm-7:30pm

Defining a BKV Cutt-Off and Profile for Early Detection of BKV Associated Nephropathy.

C. Nihei,¹ F. Agena,¹ F. Paula,¹ D. David,¹ M. Fink,³ L. Pierrotti,² E. David-Neto.¹

5:30pm-7:30pm

Does Histologic Grade in BK Polyoma Nephropathy Associate with Viral Load, Allograft Dysfunction or Allograft Loss? A Single Center Experience.

M. Swee,¹ S. Kuppachi,¹ M. Fraer,¹ P. Rastogi,² P. Ten Eyck,¹ M. Sanders.¹

5:30pm-7:30pm

Full Dose Cyclosporine Permanently Reverses Uncontrolled BK Viremia That Is Refractory to Tacrolimus Minimization.

A. Caero, M. Shah, D. McKay, J. Kerr, J. Joliat, E. Chatfield, R. Steiner.

5:30pm-7:30pm

Immunosuppressive Regimen Modification Approaches in BK Nephropathy – A Comparative Study.

H. Ahmed, A. Roche-Recinos, C. Drachenberg, R. Ugarte, N. Costa, M. Mavanur, B. Thomas, A. Haririan.

5:30pm-7:30pm

Impact of Everolimus Added to a De Novo Belatacept Regimen on the Risk of BK Viremia After Kidney Transplant.

C. Larsen,¹ M. Alseiari,² S. Chandran,² F. Vincenti,² D. Wojciechowski.¹

5:30pm-7:30pm

Improvement in Inflammatory Response Follows Clearance of BKVN.

E. Abuhelaiqa,¹ S. Salvatore,² J. Lee,¹ J. Lee,¹ T. Muthukumar,¹ S. Seshan,² D. Dadhania.¹

5:30pm-7:30pm

Increased Gene Expression of TGF-β in Peripheral Blood Mononuclear Cells from Renal Transplant Patients with Polyomavirus BK Viremi.

W. Yin.^1,2

5:30pm-7:30pm

Poor Outcome of Polyomavirus -Associated Nephropathy with Glomerular Parietal Epithelial Cells Infected by Polyomavirus.

G. Huang,¹ W. Chen,² J. Qiu,¹ X. Chen,¹ L. Chen,¹ C. Wang.¹

5:30pm-7:30pm

Role of Chemokines in Resolution of BK Virus-Associated Nephropathy and Chronicity of Pathology Changes in Kidney Transplant Recipients.

J. Zuckerman, F. Palma Diaz, C. Magyar, B. Abdalla, E. Lum, S. Bunnapradist, T. Pham, G. Dannovitch, J. Veale, H. Gritsch, E. Reed, J. Schaenman.

5:30pm-7:30pm

The Search for a Polyomavirus BK Nephropathy (BKPyVN)-Specific Transcriptomic Signature.

L. Pan,¹ G. Zeng,² Z. Lyu,³ Y. Huang,² P. Randhawa.²

5:30pm-7:30pm

Treatment and Outcomes of Simultaneous Acute Rejection and Polyomavirus Allograft Nephropathy.

T. Sparkes, S. Hammad, C. Drachenberg, A. Haririan.

5:30pm-7:30pm

Which Is More Nephrotoxic to Kidney Transplants: BK Nephropathy or Rejection?

S. Parajuli, B. Astor, D. Kaufman, B. Muth, M. Mohamed, N. Garg, A. Djamali, D. Mandelbrot.